Loading

Clinical Biomarkers of Durable Response to CiltacabtageneAutoleucelin Patients with Relapse or Refractory Multiple Myeloma from CARTITUDE-1 and CARTITUDE-4 studies

12 Feb 2026
Theatre 3
Clinical and translational excellence